Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412

author
created [InstanceEdit:9669058] Rothfels, Karen, 2019-12-02
dbId 9669059
displayName Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
journal Blood
pages 721-4
pubMedIdentifier 15790786
schemaClass LiteratureReference
title Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
url http://www.ncbi.nlm.nih.gov/pubmed/15790786
volume 106
year 2005
Cite Us!